We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$77.6B
AUM Growth
+$5.19B
(+7.2%)
Cap. Flow
+$4.38B
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
15.11%
Holding
3,002
New
251
Increased
1,435
Reduced
1,132
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$243M |
| 3 |
Tesla
TSLA
|
+$188M |
| 4 |
Adobe
ADBE
|
+$159M |
| 5 |
Infosys
INFY
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$143M |
| 2 |
Cigna
CI
|
+$133M |
| 3 |
Delta Air Lines
DAL
|
+$121M |
| 4 |
Walt Disney
DIS
|
+$120M |
| 5 |
Cisco
CSCO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.8% |
| 2 | Financials | 15.9% |
| 3 | Healthcare | 13.33% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 11.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPI
2676
DELISTED
Office Properties Income Trust
OPI
| $198K | ﹤0.01% |
198,170
-689,213
| -78% | -$1.06M |
|
2677
iShares Morningstar Multi-Asset Income ETF
IYLD
$125M
| $195K | ﹤0.01% |
10,000
| – | – |
|
2678
PubMatic
PUBM
$804M
| $195K | ﹤0.01% |
13,248
+176
| +1% | +$2.73K |
|
2679
Pulmonx
LUNG
$97.1M
| $192K | ﹤0.01% |
28,294
-35,469
| -56% | -$234K |
|
|
CDMO
2680
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $192K | ﹤0.01% |
+15,526
| New | +$178K |
|
2681
Candel Therapeutics
CADL
$780M
| $190K | ﹤0.01% |
21,859
+1,823
| +9% | +$10.8K |
|
|
VTYX
2682
DELISTED
Ventyx Biosciences
VTYX
| $188K | ﹤0.01% |
85,821
-22,940
| -21% | -$52K |
|
|
VERV
2683
DELISTED
Verve Therapeutics
VERV
| $186K | ﹤0.01% |
33,064
-42,737
| -56% | -$241K |
|
2684
Pulse Biosciences
PLSE
$3.17B
| $186K | ﹤0.01% |
10,667
+10
| +0.1% | +$176 |
|
2685
Replimune Group
REPL
$1.15B
| $185K | ﹤0.01% |
15,309
-12,477
| -45% | -$152K |
|
2686
Boston Omaha
BOC
$430M
| $185K | ﹤0.01% |
13,034
+396
| +3% | +$5.89K |
|
2687
Design Therapeutics
DSGN
$915M
| $184K | ﹤0.01% |
29,855
+19,071
| +177% | +$110K |
|
2688
Clean Energy Fuels
CLNE
$377M
| $183K | ﹤0.01% |
72,957
-48,122
| -40% | -$137K |
|
2689
Novavax
NVAX
$1.31B
| $183K | ﹤0.01% |
22,764
+4,007
| +21% | +$38.6K |
|
2690
TFS Financial
TFSL
$4.83B
| $183K | ﹤0.01% |
+14,560
| New | +$194K |
|
2691
Diamondrock Hospitality Co
DRH
$2.46B
| $183K | ﹤0.01% |
20,230
+1,449
| +8% | +$13.2K |
|
2692
Verastem
VSTM
$638M
| $182K | ﹤0.01% |
35,126
+3,816
| +12% | +$15K |
|
2693
Colony Bankcorp
CBAN
$468M
| $181K | ﹤0.01% |
+11,213
| New | +$183K |
|
2694
Rackspace Technology
RXT
$1.1B
| $178K | ﹤0.01% |
80,507
+3,484
| +5% | +$8.79K |
|
2695
Plains All American Pipeline
PAA
$16.3B
| $177K | ﹤0.01% |
+10,338
| New | +$180K |
|
2696
Cardiff Oncology
CRDF
$81.7M
| $176K | ﹤0.01% |
40,639
+9,770
| +32% | +$30.5K |
|
|
CALY
2697
Callaway Golf Company
CALY
$3.01B
| $175K | ﹤0.01% |
+22,625
| New | +$205K |
|
|
DFTX
2698
Definium Therapeutics
DFTX
$5.43B
| $175K | ﹤0.01% |
25,137
+2,364
| +10% | +$16.3K |
|
2699
Global Net Lease
GNL
$1.91B
| $175K | ﹤0.01% |
23,915
-1,041
| -4% | -$8K |
|
2700
Hyliion Holdings
HYLN
$699M
| $175K | ﹤0.01% |
66,881
+35,998
| +117% | +$100K |
|
Similar funds
VGA
AQR Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, AQR Capital Management held 3,002 positions worth $77.6B, up 7.2% from $72.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $4.38B of net new capital in Q4 2024, opening 251 new positions and adding to 1,435 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $143M trimmed.
- AQR Capital Management's largest Q4 2024 buy was iShares Russell 2000 Value ETF: 98,982 shares worth $16.2M.
- AQR Capital Management added most to Apple in Q4 2024, an estimated $523M increase.
- AQR Capital Management's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $143M.
- AQR Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $5.41M.
- AQR Capital Management's ten largest holdings make up 15% of its $77.6B portfolio in Q4 2024.
- AQR Capital Management opened 251 new positions and closed 141 in Q4 2024.
- AQR Capital Management's portfolio value rose 7.2% quarter-over-quarter to $77.6B.
Based on AQR Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.